These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1329259)

  • 1. Could non steroidal anti-inflammatory drugs be used to potentiate L.M.W.H. activity in thrombosis? (Part II).
    Doutremepuich F; Lalanne MC; Slimani M; Doutremepuich C
    Thromb Res; 1992 May; 66(4):445-9. PubMed ID: 1329259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could non steroidal anti-inflammatory drugs be used to potentiate L.M.W.H activity in thrombosis? (Part I).
    Doutremepuich C; Lalanne MC; Doutremepuich F; Francois C; Dosque JP; Sassoust G
    Thromb Res; 1991 Jul; 63(1):13-9. PubMed ID: 1658961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on the antithrombotic efficacy of four low-molecular-weight heparins in three different models of experimental venous thrombosis.
    Monreal M; Silveira P; Monreal L; Monasterio J; Angles AM; Lafoz E; Lorente L
    Haemostasis; 1991; 21(2):91-7. PubMed ID: 1660013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of heparin and a low molecular weight heparin fraction of the leukocytes in an experimental venous thrombosis model.
    Doutremepuich C; Toulemonde F; de Seze O; Pereira F; Anne MC; Doutremepuich F
    J Leukoc Biol; 1987 Dec; 42(6):628-31. PubMed ID: 2824648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low molecular weight heparins].
    Doutremepuich C; Lalanne MC; Guyot M; Doutremepuich F; Fernandez G; De Seze O; Deharo E; Vairel EG; Quilichini R
    Ann Pharm Fr; 1989; 47(3):109-16. PubMed ID: 2561387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the anticoagulant and anti-thrombotic effects of unfractionated heparin and a low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosis.
    Diquélou A; Dupouy D; Cariou R; Sakariassen KS; Boneu B; Cadroy Y
    Thromb Haemost; 1995 Nov; 74(5):1286-92. PubMed ID: 8607111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative monitoring of low molecular weight heparin prophylaxis in high-risk patients.
    Bacher P; Horst B; Breyer HG; Hoppensteadt DA; Walenga JM; Fareed J
    Semin Thromb Hemost; 1993; 19 Suppl 1():73-8. PubMed ID: 8395735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could thrombus age be a modulator of heparin or L.M.W.H. activities?
    Doutremepuich C; Lalanne MC; Doutremepuich F; Guyot M; De Sèze O
    Thromb Res; 1989 Aug; 55(4):407-17. PubMed ID: 2554523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic effect of two low molecular weight thrombin inhibitors and a low-molecular weight heparin in a caval vein thrombosis model in the rat.
    Eriksson BI; Carlsson S; Halvarsson M; Risberg B; Mattsson C
    Thromb Haemost; 1997 Nov; 78(5):1404-7. PubMed ID: 9408027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic effects of heparin and related agents.
    Hladovec J; Kornalík F
    Cor Vasa; 1991; 33(1):68-74. PubMed ID: 1655354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma antifactor Xa activity and the antithrombotic activity of heparins of different molecular mass.
    Bianchini P; Bergonzini GL; Parma B; Osima B
    Haemostasis; 1995; 25(6):288-98. PubMed ID: 8586320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinations of low doses of unfractionated heparin and of low-molecular-weight heparin prevent experimental venous thrombosis.
    Carelli G; Maffei FH; Mattar L; Ferrari IC; Thomazini-Santos IA; de Carvalho LR
    Pathophysiol Haemost Thromb; 2005; 34(6):263-8. PubMed ID: 16772737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative study of the action of preparations of high- and low-molecular weight heparin on hemostatic indices in vitro and in their intravenous administration to animals].
    Kudriashov BA; Pastorova VE; Liapina LA; Kondashevskaia MV; Azieva LD; Sukhanov IuS; Fedeniuk PV; Vasiukov SE; Cherstvova LG
    Eksp Klin Farmakol; 1992; 55(1):35-8. PubMed ID: 1339042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review.
    Wichers IM; Di Nisio M; Büller HR; Middeldorp S
    Haematologica; 2005 May; 90(5):672-7. PubMed ID: 15921382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparins: antithrombotic and haemorrhagic effects and standardization.
    Barrowcliffe TW; Thomas DP
    Acta Chir Scand Suppl; 1988; 543():57-64. PubMed ID: 2847459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the low molecular weight heparin/non steroidal anti-inflammatory drugs association on an experimental thrombosis induced by laser.
    Doutremepuich F; Aguejouf O; Imbault P; Oualane FA; Doutremepuich C
    Thromb Res; 1995 Feb; 77(4):311-9. PubMed ID: 7740522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative.
    Kaiser B; Hauptmann J; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):119-25. PubMed ID: 2459005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacology of low molecular weight heparins: implications of manufacturing processes on biological effects.
    Doutremepuich C; Guyot M; Lalanne MC; Deharo E; Walenga JM; Fareed J
    Thromb Res; 1989 Aug; 55(4):419-26. PubMed ID: 2554524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis.
    Superficial Thrombophlebitis Treated By Enoxaparin Study Group
    Arch Intern Med; 2003 Jul; 163(14):1657-63. PubMed ID: 12885680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of taurolidine on experimental thrombus formation.
    Kaptanoglu L; Kucuk HF; Colak E; Kurt N; Bingul SM; Akyol H; Torlak OA; Yazici F
    Eur J Pharmacol; 2008 Jan; 578(2-3):238-41. PubMed ID: 17961549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.